- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic heart failure
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 460KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 74KB)
Empagliflozin – March 2024
Empagliflozin: Tablet 10 mg; Jardiance®
Last updated
30 May 2025